Could your own immune cells keep liver cancer from coming back?
NCT ID NCT07709299
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This trial investigates whether giving liver cancer patients infusions of their own immune cells, called cytokine-induced killer (CIK) cells, after surgery is safe and feasible. The cells are collected from the patient's blood, grown in a lab, and then returned through six intravenous infusions over two months. The study includes up to 6 participants with early-stage liver cancer who have had their tumor removed, and follows them for six months to monitor side effects and early signs of recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a patient's own immune cells (cytokine-induced killer cells) grown in a lab and given back as infusions
- What this could lead to
- If safe and feasible, this approach could offer a new way to reduce the risk of liver cancer returning after surgery.
- What could go wrong
- This is a very early, small trial with only 6 participants, so results may not apply broadly. The treatment could cause side effects or fail to prevent cancer recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Liver Transplant and Surgery Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences
Tehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple therapy shrink untreatable liver tumors?
- Breath of life: new test could sniff out gut cancers before they spread
- Immune cell therapy takes on untreatable liver cancer
- New ultrasound technique could reveal hidden blood vessels in liver tumors
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Blood type no barrier? study tests liver transplant success across ABO barriers